92 related articles for article (PubMed ID: 17944058)
1. Advanced glycation end products inhibit production and activity of matrix metalloproteinase-2 in human umbilical vein endothelial cells.
Gao L; Kang L; Chen Q; Chen C; Xu B; Jiang S
J Int Med Res; 2007; 35(5):709-15. PubMed ID: 17944058
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro.
Hoffmann S; Friedrichs U; Eichler W; Rosenthal A; Wiedemann P
Graefes Arch Clin Exp Ophthalmol; 2002 Dec; 240(12):996-1002. PubMed ID: 12483322
[TBL] [Abstract][Full Text] [Related]
4. [Advanced glycation end products inhibit production of nitric oxide by human endothelial cells through activation of the p38 signal pathway].
Guo Z; Hou F; Zhang X; Liu Z; Wang L
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1328-31. PubMed ID: 12509937
[TBL] [Abstract][Full Text] [Related]
5. Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells.
Higashimoto Y; Matsui T; Nishino Y; Taira J; Inoue H; Takeuchi M; Yamagishi S
Microvasc Res; 2013 Nov; 90():64-70. PubMed ID: 24012635
[TBL] [Abstract][Full Text] [Related]
6. cAMP involvement in the expression of MMP-2 and MT-MMP1 metalloproteinases in human endothelial cells.
Peracchia F; Tamburro A; Prontera C; Mariani B; Rotilio D
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3185-90. PubMed ID: 9409309
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
Zhang FL; Gao HQ; Shen L
J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
[TBL] [Abstract][Full Text] [Related]
8. MT1-MMP regulates MMP-2 expression and angiogenesis-related functions in human umbilical vein endothelial cells.
Lee H; Chang KW; Yang HY; Lin PW; Chen SU; Huang YL
Biochem Biophys Res Commun; 2013 Jul; 437(2):232-8. PubMed ID: 23796708
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-1 of gingival fibroblasts influenced by advanced glycation end products (AGEs) and their association with receptor for AGEs and nuclear factor-κB in gingival connective tissue.
Yu S; Li H; Ma Y; Fu Y
J Periodontol; 2012 Jan; 83(1):119-26. PubMed ID: 21563948
[TBL] [Abstract][Full Text] [Related]
10. Perivascular cells regulate endothelial membrane type-1 matrix metalloproteinase activity.
Lafleur MA; Forsyth PA; Atkinson SJ; Murphy G; Edwards DR
Biochem Biophys Res Commun; 2001 Mar; 282(2):463-73. PubMed ID: 11401482
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human endothelial cell nitric oxide synthesis by advanced glycation end-products but not glucose: relevance to diabetes.
Xu B; Ji Y; Yao K; Cao YX; Ferro A
Clin Sci (Lond); 2005 Nov; 109(5):439-46. PubMed ID: 16022682
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of advanced glycation end products-induced hyperpermeability in endothelial cells].
Guo XH; Huang QB; Chen B; Wang SY; Hou FF; Fu N
Sheng Li Xue Bao; 2005 Apr; 57(2):205-10. PubMed ID: 15830106
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor inducing angiogenesis through modulation of matrix-degrading proteases.
Sun CY; Hu Y; Wang HF; He WJ; Wang YD; Wu T
Chin Med J (Engl); 2006 Apr; 119(7):589-95. PubMed ID: 16620701
[TBL] [Abstract][Full Text] [Related]
14. Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin.
Dahi S; Lee JG; Lovett DH; Sarkar R
J Vasc Surg; 2005 Sep; 42(3):539-45. PubMed ID: 16171603
[TBL] [Abstract][Full Text] [Related]
15. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2.
Schwartz JD; Monea S; Marcus SG; Patel S; Eng K; Galloway AC; Mignatti P; Shamamian P
J Surg Res; 1998 Apr; 76(1):79-85. PubMed ID: 9695744
[TBL] [Abstract][Full Text] [Related]
16. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
17. N-butanol extracts of Morinda citrifolia suppress advanced glycation end products (AGE)-induced inflammatory reactions in endothelial cells through its anti-oxidative properties.
Ishibashi Y; Matsui T; Isami F; Abe Y; Sakaguchi T; Higashimoto Y; Yamagishi SI
BMC Complement Altern Med; 2017 Mar; 17(1):137. PubMed ID: 28259164
[TBL] [Abstract][Full Text] [Related]
18. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells.
Oak MH; El Bedoui J; Anglard P; Schini-Kerth VB
Circulation; 2004 Sep; 110(13):1861-7. PubMed ID: 15364805
[TBL] [Abstract][Full Text] [Related]
19. Paeoniflorin protects HUVECs from AGE-BSA-induced injury via an autophagic pathway by acting on the RAGE.
Chen Y; Du X; Zhou Y; Zhang Y; Yang Y; Liu Z; Liu C; Xie Y
Int J Clin Exp Pathol; 2015; 8(1):53-62. PubMed ID: 25755692
[TBL] [Abstract][Full Text] [Related]
20. High glucose and Nepsilon-(carboxymethyl) lysine bovine serum albumin modulate release of matrix metalloproteinases in cultured human endothelial cells.
Gharagozlian S; Henriksen T; Kolset SO
Eur J Nutr; 2006 Aug; 45(5):283-90. PubMed ID: 16705353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
